Monday’s Oral Presentations session “Innovative Diabetes Education Across Diverse Populations” will feature a series of studies looking at self-management education strategies for patients as well as diabetes care education for community care workers, trainees, and primary care physicians. Nicolas Cuttriss, MD, MPH, and Louise A. Reagan, PhD, ANP, preview their presentations.

The Monday afternoon session “The Wide-Ranging Field of Clinical Nutrition Research—From the Role of Nutrients to How We Eat” will highlight results from eight recent studies examining dietary and nutritional interventions in diabetes patients. Three of the presenters, including Stephan Martin, MD, and William S. Yancy Jr., MD, MHS, talked to ADAMeetingNews.org about their research.

The National Scientific & Health Care Achievement Awards Presentation and Outstanding Scientific Achievement Award Lecture will begin at 10:10 a.m. Monday. Sadaf Farooqi, MB, ChB (Hons), PhD, will present the Outstanding Scientific Achievement Award Lecture “Obesity and the Biology of Weight Regulation” at 11:00 a.m. to conclude the session.

The longest-running study of type 2 diabetes in young people, Longitudinal Outcomes in Youth with Type 2 Diabetes—The TODAY2 Study, is winding down. Results to date show that youth-onset type 2 diabetes is more aggressive than adult-onset disease, according to Philip Zeitler, MD, PhD.

The most important thing that diabetes educators and caregivers can give to their patients is hope, according to this year’s Outstanding Educator in Diabetes Award recipient, Virginia Valentine, APRN, BC-ADM, CDE, FAADE, who discussed the challenges of overcoming the stigma of diabetes and obesity in her Scientific Sessions address on Saturday.

In her address to Scientific Sessions attendees Saturday morning, ADA President, Health Care & Education Gretchen Youssef, MS, RDN, CDE, urged the audience to become active advocates for improving patient access to both high-quality diabetes care and self-management education and support.

A growing body of evidence suggests that glucagon-like peptide-1 (GLP-1) medications could become a common approach to improving glucose control in a variety of clinical situations. Richard E. Pratley, MD, and several other researchers presented studies Saturday morning that showed generally favorable results from novel and familiar GLP-1 receptor agonists in type 2 diabetes, type…

During Saturday’s ADA Diabetes Care Symposium, Juliana CN Chan, MB, ChB, MD, FRCP, discussed how a research-driven quality improvement initiative in Hong Kong evolved to help reform the delivery of diabetes care in China.

Sunday will feature more highly anticipated study announcements than any other day of the 79th Scientific Sessions. Here’s an ADAMeetingNews.org preview of the the four Sunday sessions featuring major study results.

The Centers for Medicare and Medicaid Services approved reimbursement for select continuous glucose monitoring (CGM) devices in 2017, but there are limited data on the use of CGM, insulin pumps, and other advanced diabetes technologies in older adults. Three clinical researchers, including Medha Munshi, MD, will share their insights, experience, and trial results during Sunday’s…